发病率,发病率和血栓塞栓事件在多细胞真血症:基于德国纵向健康声明数据的研究
Karina C Manz1, Anja Mocek2, Bashar Morouj3
1IGES Institut GmbH, Berlin, Germany. Karina.Manz@iges.com.
Annals of hematology
|February 9, 2025
概括
多细胞血病 (PV) 在德国每10万人中发生28.6例. 许多高风险患者没有接受指导方针推的细胞减小药物,可能会增加血栓栓塞事件.
科学领域:
- 血液学 血液学 血液学
- 流行病学 流行病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在德国,关于多细胞血病 (PV) 流行病学和细胞减少治疗的数据有限.
- 血清多细胞是一种骨髓扩散性新生体,其特征是红细胞的生产增加.
研究的目的:
- 为了估计德国的PV流行率和发病率.
- 在PV患者中描述细胞还原药物的使用.
- 评估在持续细胞减小疗法治疗的患者中发生的血栓栓塞事件 (TE).
主要方法:
- 使用匿名的德国健康声明数据进行的观察性研究.
- 对TEs的PV流行,发病率和风险因素的分析.
- 在接受氧尿素治疗的患者中,TEs的比较与ruxolitinib.
主要成果:
- 估计在德国的PV流行率为28.6/100,000,发病率为3.3/100,000 (2021年).
- 83.2%的流行PV患者有TE的高风险,但43.6%没有接受细胞减小治疗.
- 与氧尿素不耐受/耐药患者 (56.3%) 相比,鲁克索利替尼的TEs比例较低 (35.8%在3年内).
结论:
- 目前在德国的细胞还原疗法使用不足以达到治疗指南.
- 低于最佳的治疗可能会导致PV患者的可预防的血栓栓塞并发症.
- 卢克索利提尼布可能在特定的患者亚组中提供更好的TEs安全性.
相关概念视频
Disorders of Hemostasis
686
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
686
Disorders of Erythrocytes
844
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
844
Anticoagulant Drugs: Low-Molecular-Weight Heparins
601
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
601
Overview of the Vascular System
2.7K
The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
2.7K


